Our Science
Powerful innovation to transform MS
We're committed to rigorous and ongoing evaluation.
Browse our latest publications below.
Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease Activity: A Case Series from Real-World Use
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Urinary Tract Infections in People with Multiple Sclerosis: A Real-World Administrative Claims Study
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Substantial Variability of Neurologist Decision-Making Based on MRI Reports
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Blood Serum Proteome Correlates of Multiple Sclerosis Disease Progression as evaluated by Neuropsychological Test Outcomes: A 5-Year Longitudinal Study
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Serum Biomarkers of Brain Atrophy in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Real World Considerations Regarding MRI Use in a Clinic Setting
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Sex-Specific Brain Charts for Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Glial Cell Injury and MRI Measures of Chronic Multiple Sclerosis Inflammation
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Association between Serum Biomarkers Profile and real world Evidence of Disability in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF
Serum Biomarkers of Progression by Proteomic Search in Extreme MS Phenotypes
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Investigation of Serum Based Proteomic Biomarker Signatures Relative to Steroid Responsiveness and Disease Activity Status in Relapsing Multiple Sclerosis Patients
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Blood Serum Proteome Correlates of Multiple Sclerosis Disease Progression as evaluated by Clinical and Brain Atrophy Outcomes: A 5-Year Longitudinal Study
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Longitudinal Testing with a Multivariate Blood Serum Biomarker Panel for Multiple Sclerosis Disease Activity: Patterns of Results in a Real-World Clinical Setting
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Clinical Phenotypes from Blood Serum Protein Concentration
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Differential Diagnosis Of MS Patients Versus Disease State Controls and Classification of MS Subtypes Using Serum Proteomics
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Matched Plasma Modification for Calculating a Disease Activity Score in a Serum-Validated Multivariate Proteomic Multiple Sclerosis Disease Activity Test
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Study Design: The Impact of Quantitative Structured MRI Reports on Clinical Decision Making in MS
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Multiple Sclerosis MRI Reports Vary Among Neuroradiologists
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Tracking Longitudinal Change in Brain Volumes through Conditional Quantiles
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Brain Charts for People Living with Multiple Sclerosis
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Multivariate Proteomic Analysis and the Relationship with Axonal Pathology in Multiple Sclerosis: A Longitudinal 5-Year Diffusion Tensor Imaging Study
Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights
Research Presented at the Annual CMSC Meeting — June 1-4, 2022
Download PDF
Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Estimation of Disability Status from Blood Serum Protein Concentrations
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Accounting for Variance in Brain Atrophy Measurements by Quantifying Image Quality Differences across Longitudinal Imaging Studies
Research Presented at the Annual ACTRIMS Meeting — February 24-26, 2022
Download PDF
Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021
Download PDF
Clinical Validation Study Results of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis
Research Presented at the Annual ECTRIMS Meeting Virtual Conference — October 13-15, 2021
Download PDF
Clinical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021
Download PDF
Integrated Analysis of Novel MRI and Blood Serum Biomarkers for the Estimation and Prediction of MS Disease Activity and Progression
Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021
Download PDF
Proteomic Serum Biomarker Signatures Associated with Patient Reported Outcomes in Multiple Sclerosis
Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021
Download PDF
Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software
Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021
Download PDF
Development of a Custom Multivariate Proteomic Serum Based Assay for Association with Radiographic and Clinical Endpoints in MS
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
Cross-sectional and longitudinal estimation of radiographic and clinical endpoints to quantify MS disease trajectory with blood serum protein levels.
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
Improving Patient Outcomes through a Comprehensive Care Management Platform Measuring Outcomes and Value: an Integrated, Novel solution for Generating insights in MS (MOVING MS)
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
From proteome to interactome: a mechanistic approach to MS biomarker discovery
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
Improved detection of clinically relevant MRI findings in Multiple Sclerosis radiology reports using FDA-approved quantitative software
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
BrainGraph: A Novel Visualization of MRI Data as a 3D Graph to Reveal Temporal Features of Disease Progression In Patients with Multiple Sclerosis
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
High throughput lesion evaluation and quality control for incorporating quantitative imaging metrics into clinical practice
Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020
Download PDF
Multivariate protein biomarker models more accurately predict multiple sclerosis MRI disease activity compared to serum levels of neurofilament light chain alone
Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019
Download PDF
Classification of high versus low annualized relapse rate status in subjects with relapsing-remitting multiple sclerosis using multivariate serum protein biomarker models
Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019
Download PDF
Clinical disease activity status (exacerbation versus quiescence) in subjects with relapsing-remitting multiple sclerosis is accurately classified using multivariate serum protein biomarker models
Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019
Download PDF
